QITIAN Technology Group Co., Ltd. (SHE:300061)
China
· Delayed Price · Currency is CNY 12.39
-0.28 (-2.21%)
At close: May 30, 2025, 2:57 PM CST
QITIAN Technology Group Revenue
QITIAN Technology Group had revenue of 125.21M CNY in the quarter ending March 31, 2025, a decrease of -38.10%. This brings the company's revenue in the last twelve months to 549.72M, down -42.17% year-over-year. In the year 2024, QITIAN Technology Group had annual revenue of 626.79M, down -35.71%.
Revenue (ttm)
549.72M
Revenue Growth
-42.17%
P/S Ratio
14.85
Revenue / Employee
830.39K
Employees
662
Market Cap
8.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 626.79M | -348.10M | -35.71% |
| Dec 31, 2023 | 974.89M | -280.79M | -22.36% |
| Jan 1, 2023 | 1.26B | 201.31M | 19.09% |
| Jan 1, 2022 | 1.05B | -410.83M | -28.04% |
| Dec 31, 2020 | 1.47B | 231.75M | 18.79% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |